T38Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
Code usage status
Primary diagnosis
Select a more specific code
Apply only when it matches the confirmed diagnosis and the documented clinical record.
Specificity
Do not use T38 directly
Use the most specific code supported by the record.
- Official Vietnamese name
- Ngộ độc do nội tiết tố [hormon] và/hoặc chất tổng hợp thay thế và/hoặc đối kháng của chúng, không phân loại mục khác
- Additional WHO coding guidance
- Excl.: mineralocorticoids and their antagonists (T50.0) oxytocic hormones (T48.0) parathyroid hormones and derivatives (T50.9)
Related T38 codes
T38.0
Primary diagnosis candidate
Glucocorticoids and synthetic analogues
T38.1
Primary diagnosis candidate
Thyroid hormones and substitutes
T38.2
Primary diagnosis candidate
Antithyroid drugs
T38.3
Primary diagnosis candidate
Insulin and oral hypoglycaemic [antidiabetic] drugs
T38.4
Primary diagnosis candidate
Oral contraceptives Multiple- and single-
T38.5
Primary diagnosis candidate
Other estrogens and progestogens
T38.6
Primary diagnosis candidate
Antigonadotrophins , antiestrogens, antiandrogens, not elsewhere classified
T38.7
Primary diagnosis candidate
Androgens and anabolic congeners
T38.8
Primary diagnosis candidate
Other and unspecified hormones and their synthetic substitutes
T38.9
Primary diagnosis candidate
Other and unspecified hormone antagonists
Clinical record checklist
View coding guide →- Confirm that the code matches the final documented diagnosis.
- Use one primary-diagnosis code and record only relevant additional conditions.
- Review Ministry indicators, inclusions, exclusions and notes.
- Do not infer a diagnosis beyond the clinical record.
2026 regulatory basis
Indicators are taken from columns 24–29 of the classification accompanying Circular 06/2026/TT-BYT, cross-referenced with Decision 1849/QĐ-BYT and Official Dispatch 4059/BYT-BH.
